Human Milk Oligosaccharides Market Share, Siae, Growth &
Trend to 2022: Radiant Insights, Inc
Global human milk oligosaccharides market is expected to reach USD 134.7 million by 2022, according
to a new report by Grand View Research, Inc. The human milk oligosaccharides industry is expected to
witness significant demand owing to increasing need from infant formula and functional food & beverage
applications.
Numerous players have been investing for development of new technologies for commercial scale
product manufacturing, thus augmenting growth. For instance, Inbiose N.V. uses fermentation process for
commercial scale production of human milk oligosaccharides.
Rising concern regarding gut health coupled with increasing dairy industry is expected to augment
product demand in dairy and pharmaceutical applications. Changing consumer lifestyles and shift towards
nutritious food is expected to boost product need over the forecast period. In addition, issues related to
infant malnutrition and mortality throughout the world is expected to augment product over the next
seven years.
Read Complete Report with TOC @ http://www.radiantinsights.com/research/human-milkoligosaccharides-market
Further key findings from the report suggest:
Infant Formula was the largest application, accounting for over 70% of global volume in 2014. High
infant mortality rate coupled with increased need of the product for infants deprived of mother's milk is
expected to propel demand.
Functional food & beverages are expected to witness rise on account of growing awareness towards gut
health. In addition, rapidly growing need for better healthcare services and nutritional food products in
Asia Pacific and Latin America is expected to fuel growth over the next seven years. The segment is
expected to grow at a CAGR of 17.9% from 2015 to 2022.
Europe was the dominant region in terms of volume, accounting for over 35.0% of the total share in 2014
primarily due to growing demand for prebiotic products. Europe human milk oligosaccharides demand is
expected to grow at a significant rate owing to regulations promoting use of 2'FL and LNnT in infant
formulas.
The global market is consolidated with limited players dominating the industry. Key companies present
include Inbiose, Elicityl SA, Jennewein Biotechnologie, Glycom, Medolac Laboratories, ZuChem, and
Glycosyn. These companies are extensively involved in R&D activities for the product. Moreover, some
of the players including Glycom A/S are integrated across the value chain, where they produce the raw
materials used in manufacturing of HMOs.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. HMO Market - Industry Summary and Key Buying Criteria, 2012 - 2022
Chapter 3. HMO Industry Outlook
3.1. HMO market segmentation
3.2. HMO market size and growth prospects, 2012 – 2022
Read Complete Report with TOC @ http://www.radiantinsights.com/research/human-milkoligosaccharides-market
3.3. HMO market - Value chain analysis
3.3.1. Vendor landscape
3.4. Raw material outlook, 2012 - 2022
3.5. Technology overview
3.6. Regulatory framework
3.7. HMO market dynamics
3.7.1. Market driver analysis
3.7.2. Market restraint analysis
3.8. Key market opportunities - Prioritized
3.9. Industry analysis - Porter's
3.10. HMO market PESTEL analysis, 2014
3.11. HMO market competitive landscape, 2014
3.12. HMO market pricing trends
Chapter 4. HMO Application Outlook
4.1. Global HMO market share by application, 2014 & 2022
4.2. Infant Formula
4.2.1. Market estimates and forecast, 2012 - 2022
4.2.2. Market estimates and forecast, by region, 2012 - 2022
4.3. Functional Food & Beverages
4.3.1. Market estimates and forecast, 2012 - 2022
4.3.2. Market estimates and forecast, by region, 2012 - 2022
4.4. Food Supplements
4.4.1. Market estimates and forecast, 2012 - 2022
4.4.2. Market estimates and forecast, by region, 2012 – 2022
Read Complete Report with TOC @ http://www.radiantinsights.com/research/human-milkoligosaccharides-market
4.5. Others
4.5.1. Market estimates and forecast, 2012 - 2022
4.5.2. Market estimates and forecast, by region, 2012 - 2022
Chapter 5. HMO Regional Outlook
5.1. Global HMO market share by region, 2014 & 2022
5.2. North America
5.2.1. North America market estimates and forecast, 2012 - 2022
5.2.2. North America market estimates and forecast by application, 2012 - 2022
5.2.3. U.S.
5.2.3.1. U.S. market estimates and forecast by application, 2012 - 2022
5.3. Europe
5.3.1. Europe market estimates and forecast, 2012 - 2022
5.3.2. Europe market estimates and forecast by application, 2012 - 2022
5.3.3. UK
5.3.3.1. UK market estimates and forecast by application, 2012 - 2022
5.3.4. Germany
5.3.4.1. Germany market estimates and forecast by application, 2012 - 2022
5.4. Asia Pacific
5.4.1. Asia Pacific market estimates and forecast, 2012 - 2022
5.4.2. Asia Pacific market estimates and forecast by application, 2012 - 2022
5.4.3. China
5.4.3.1. China market estimates and forecast by application, 2012 - 2022
5.4.4. Japan
Read Complete Report with TOC @ http://www.radiantinsights.com/research/human-milkoligosaccharides-market
5.4.4.1. Japan market estimates and forecast by application, 2012 - 2022
5.5. Latin America
5.5.1. Latin America market estimates and forecast, 2012 - 2022
5.5.2. Latin America market estimates and forecast by application, 2012 - 2022
5.5.3. Brazil
5.5.3.1. Brazil market estimates and forecast by application, 2012 - 2022
5.6. MEA
5.6.1. MEA market estimates and forecast, 2012 - 2022
5.6.2. MEA market estimates and forecast by application, 2012 - 2022
Chapter 6. Competitive Landscape
6.1. Inbiose
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2. Elicityl SA
6.2.1 Company Overview
6.2.2 Financial Performance
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
Read Complete Report with TOC @ http://www.radiantinsights.com/research/human-milkoligosaccharides-market
6.3. Jennewein Biotechnologie
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4. Glycom
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5. Medolac Laboratories
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6. ZuChem
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7. Glycosyn
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
Read Complete Report with TOC @ http://www.radiantinsights.com/research/human-milkoligosaccharides-market
List of Tables
1. HMO - Industry Summary & Key Buying Criteria
2. Global HMO market estimates and forecast, 2012 - 2022 (Grams) (USD 000)
3. Global HMO market volume, by region, 2012 - 2022 (Grams)
4. Global HMO market revenue, by region, 2012 - 2022 (USD 000)
5. Global HMO market volume, by application, 2012 - 2022 (Grams)
6. Global HMO market revenue, by application, 2012 - 2022 (USD 000)
7. Vendor landscape
8. HMO- Key market driver analysis
9. HMO - Key market restraint analysis
10. Global HMO market estimates and forecast in infant formula, 2012 - 2022 (Grams) (USD 000)
11. Global HMO market estimates and forecast in infant formula, by region, 2012 - 2022 (Grams)
12. Global HMO market estimates and forecast in infant formula, by region, 2012-2022, (USD 000)
13. Global HMO market estimates and forecast in functional food & beverages, 2012 - 2022 (Grams)
(USD 000)
14. Global HMO market estimates and forecast in functional food & beverages, by region, 2012 - 2022
(Grams)
15. Global HMO market estimates and forecast in functional food & beverages, by region, 2012-2022,
(USD 000)
16. Global HMO market estimates and forecast in food supplements, 2012 - 2022 (Grams) (USD 000)
17. Global HMO market estimates and forecast in food supplements, by region, 2012 - 2022 (Grams)
18. Global HMO market estimates and forecast in food supplements, by region, 2012-2022, (USD 000)
19. Global HMO market estimates and forecast in other applications, 2012 - 2022 (Grams) (USD 000)
Read Complete Report with TOC @ http://www.radiantinsights.com/research/human-milkoligosaccharides-market
20. Global HMO market volume in other applications, by region, 2012 - 2022 (Grams)
21. Global HMO market revenue in other applications, by region, 2012-2022, (USD 000)
22. North America HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
23. North America HMO market volume, by application, 2012 - 2022 (Grams)
24. North America HMO market revenue, by application, 2012 - 2022 (USD 000)
25. U.S HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
26. U.S. HMO market volume, by application, 2012 - 2022 (Grams)
27. U.S. HMO market revenue, by application, 2012 - 2022 (USD 000)
28. Europe HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
29. Europe HMO market volume, by application , 2012 - 2022 (Grams)
30. Europe HMO market revenue, by application, 2012 - 2022 (USD 000)
31. UK HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
32. UK HMO market volume, by application , 2012 - 2022 (Grams)
33. UK HMO market revenue, by application, 2012 - 2022 (USD 000)
34. Germany HMO market estimates and forecast, 2012 - 2022 (Grams) (USD 000)
35. Germany HMO market volume, by application , 2012 - 2022 (Grams)
36. Germany HMO market revenue, by application, 2012 - 2022 (USD 000)
37. Asia Pacific HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
38. Asia Pacific HMO market volume, by application, 2012 - 2022 (Grams)
39. Asia Pacific HMO market revenue, by application 2012 - 2022 (USD 000)
40. China HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
41. China HMO market volume, by application, 2012 - 2022 (Grams)
42. China HMO market revenue, by application 2012 - 2022 (USD 000)
Read Complete Report with TOC @ http://www.radiantinsights.com/research/human-milkoligosaccharides-market
43. Japan HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
44. Japan HMO market volume, by application, 2012 - 2022 (Grams)
45. Japan HMO market revenue, by application 2012 - 2022 (USD 000)
46. Latin America HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
47. Latin America HMO market volume, by application , 2012 - 2022 (Grams)
48. Latin America HMO market revenue, by application, 2012 - 2022, (USD Thousand)
49. Brazil HMO market estimates and forecast, 2012 - 2022 (Grams) (USD 000)
50. Brazil HMO market volume, by application, 2012 - 2022 (Grams)
51. Brazil HMO market revenue, by application 2012 - 2022 (USD 000)
52. MEA HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
53. MEA HMO market volume, by application, 2012 - 2022 (Grams)
54. MEA HMO market revenue, by application 2012 - 2022 (USD 000)
List of Figures
1. HMO market segmentation
2. Global HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
3. HMO Market- Value chain analysis
4. HMO: Raw material outlook
5. HMO market dynamics
6. Global dairy product market, 2008 & 2012 (Million Tons)
7. Global Dietary Supplements Market, 2012-2020, (USD Million)
8. HMO- Key opportunities prioritized
Read Complete Report with TOC @ http://www.radiantinsights.com/research/human-milkoligosaccharides-market
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and individuals procure market research
reports, helping them in the decision making process. We have a comprehensive collection of reports,
covering over 40 key industries and a host of micro markets. In addition to over extensive database of
reports, our experienced research coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For More Information, Visit Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Blog URL: http://www.radiantinsightsinc.blogspot.com